Home  

Enter a class name or drug name above to search the database.

Increased Protein Synthesis [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
50242-175 EVRYSDI Risdiplam Genentech, Inc. POWDER, FOR SOLUTION 2020-08-07
50242-202 EVRYSDI Risdiplam Genentech, Inc. TABLET 2025-02-11
60923-227 AMONDYS 45 casimersen Sarepta Therapeutics, Inc. INJECTION 2021-02-25
60923-465 Vyondys 53 golodirsen Sarepta Therapeutics, Inc. INJECTION 2019-12-12
64406-058 Spinraza Nusinersen Biogen INJECTION, SOLUTION 2016-12-23

 Physiological Effect (PE) Classification 

Loading full table content...